Conflict of Interest

Julie & Holleman LLP has raised concerns that Tempus’s pre‑existing ownership and strategic relationship may have created conflicts of interest, questioning whether public shareholders are receiving fair value for their shares. The firm is investigating whether the $16.25 per‑share price reflects Personalis’s true worth, especially given the market’s long‑term growth potential for MRD testing.